• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名长期存活的人乳头瘤病毒相关子宫颈浆液性癌患者:病例报告

Human papillomavirus associated serous carcinoma of the uterine cervix in a patient with long-term survival: A case report.

作者信息

Huang Hui-Qiong, Yang Lu, Li Qing-Li, Sun Chun-Tang, Gong Feng-Ming

机构信息

Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

出版信息

World J Clin Cases. 2025 Aug 6;13(22):104643. doi: 10.12998/wjcc.v13.i22.104643.

DOI:10.12998/wjcc.v13.i22.104643
PMID:40771740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12188755/
Abstract

BACKGROUND

Serous carcinoma of the uterine cervix (USCC) represents a rare subtype of cervical adenocarcinoma, classified into human papillomavirus (HPV)-independent and HPV-associated types. It is characterized by high invasiveness and poor prognosis, with limited global reports on this condition.

CASE SUMMARY

A 58-year-old Chinese woman presented with painless vaginal bleeding after sexual intercourse, which appeared as droplets. HPV testing and histopathological analysis confirmed the diagnosis of HPV-associated primary serous carcinoma of the USCC. The patient underwent radical hysterectomy and was diagnosed with primary serous carcinoma of the uterine cervix, stage III C2 (FIGO 2018). A multimodal treatment approach, including surgery, radiotherapy, and chemotherapy, was administered. After additional concurrent chemoradiotherapy and three cycles of chemotherapy, the patient showed no evidence of disease progression and achieved long-term survival for 53 months.

CONCLUSION

USCC is a rare and aggressive malignancy. Upon diagnosis, multimodal treatment strategies, including surgery, radiotherapy, and chemotherapy, can effectively prolong patient survival and improve prognosis.

摘要

背景

子宫颈浆液性癌(USCC)是宫颈腺癌的一种罕见亚型,分为人乳头瘤病毒(HPV)非依赖性和HPV相关性类型。其特点是侵袭性高、预后差,全球关于这种疾病的报道有限。

病例摘要

一名58岁中国女性出现性交后无痛性阴道点滴出血。HPV检测和组织病理学分析确诊为HPV相关性原发性子宫颈浆液性癌。患者接受了根治性子宫切除术,被诊断为子宫颈原发性浆液性癌,III C2期(FIGO 2018)。采用了包括手术、放疗和化疗在内的多模式治疗方法。在额外进行同步放化疗和三个周期化疗后,患者未出现疾病进展迹象,并实现了53个月的长期生存。

结论

子宫颈浆液性癌是一种罕见且侵袭性强的恶性肿瘤。确诊后,包括手术、放疗和化疗在内的多模式治疗策略可有效延长患者生存期并改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/a8bfca339c49/wjcc-13-22-104643-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/9ff2b4a91c32/wjcc-13-22-104643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/47c12a3df735/wjcc-13-22-104643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/a8bfca339c49/wjcc-13-22-104643-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/9ff2b4a91c32/wjcc-13-22-104643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/47c12a3df735/wjcc-13-22-104643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5c/12188755/a8bfca339c49/wjcc-13-22-104643-g003.jpg

相似文献

1
Human papillomavirus associated serous carcinoma of the uterine cervix in a patient with long-term survival: A case report.一名长期存活的人乳头瘤病毒相关子宫颈浆液性癌患者:病例报告
World J Clin Cases. 2025 Aug 6;13(22):104643. doi: 10.12998/wjcc.v13.i22.104643.
2
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
3
Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.FIGO 分期(2019)IB3/II 期宫颈癌行肿瘤细胞减灭术联合放化疗与单纯放化疗的比较。
Cochrane Database Syst Rev. 2022 Sep 16;9(9):CD012246. doi: 10.1002/14651858.CD012246.pub2.
4
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
5
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.小体积原发性口咽癌的微创手术与放疗/放化疗对比
Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2.
6
Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.早期子宫颈腺癌的初次手术与单纯放疗或放化疗的比较
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD006248. doi: 10.1002/14651858.CD006248.pub3.
7
Papanicolaou Smear巴氏涂片检查
8
Adjuvant platinum-based chemotherapy for early stage cervical cancer.早期宫颈癌的铂类辅助化疗。
Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD005342. doi: 10.1002/14651858.CD005342.pub4.
9
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
10
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.

本文引用的文献

1
2020 WHO Classification of Female Genital Tumors.《2020年世界卫生组织女性生殖器官肿瘤分类》
Geburtshilfe Frauenheilkd. 2021 Oct;81(10):1145-1153. doi: 10.1055/a-1545-4279. Epub 2021 Oct 6.
2
Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs.子宫颈浆液性癌:与其他女性器官浆液性癌不同的临床病理特征。
J Obstet Gynaecol Res. 2020 Jan;46(1):153-160. doi: 10.1111/jog.14142. Epub 2019 Oct 22.
3
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research.
妇科癌症中的免疫检查点抑制剂:文献更新与临床研究展望
Anticancer Res. 2017 Nov;37(11):5955-5965. doi: 10.21873/anticanres.12042.
4
Cervical carcinomas with a micropapillary component: a clinicopathological study of eight cases.具有微乳头状成分的宫颈癌:8 例临床病理研究。
Histopathology. 2018 Mar;72(4):626-633. doi: 10.1111/his.13419. Epub 2017 Dec 14.
5
Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC1 immunostain.大肠微乳头癌中腺上皮细胞的极性反转及上皮膜抗原/黏蛋白1免疫染色
Pathology. 2014 Oct;46(6):527-32. doi: 10.1097/PAT.0000000000000144.
6
Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.乳腺单纯浸润性微乳头状癌中的极性基因改变。
Breast Cancer Res. 2014 May 8;16(3):R46. doi: 10.1186/bcr3653.
7
Papillary serous carcinoma of the uterine cervix with lung metastasis.伴有肺转移的子宫颈乳头状浆液性癌
Case Rep Oncol Med. 2014;2014:683103. doi: 10.1155/2014/683103. Epub 2014 Mar 4.
8
Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.他莫昔芬治疗双侧乳腺癌后发生的宫颈乳头状浆液性腺癌。
Anticancer Res. 2012 Nov;32(11):5075-8.
9
Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature.宫颈浆液性腺癌 12 例临床病理分析及文献复习
Gynecol Obstet Invest. 2012;73(1):26-31. doi: 10.1159/000329319. Epub 2011 Aug 26.
10
Papillary serous adenocarcinoma of the uterine cervix: a case report.
Eur J Gynaecol Oncol. 2011;32(2):240-2.